Allarity Therapeutics appoints Jesper Høiland to board, replacing Joseph Vazzano

Allarity Therapeutics, Inc.

Joseph Vazzano resigned as director effective June 30, 2025.
Jesper Høiland appointed director effective June 30, 2025; term expires at 2026 annual meeting.
Høiland joins Audit, Compensation, and Nominating & Governance Committees.
Høiland receives $50,000 annual retainer plus committee fees ($7,500/$5,000/$4,000).
Høiland had served as strategic consultant since Oct 2024; background includes Novo Nordisk and Radius Health.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jesper Høiland

director

ALLR · Allarity Therapeutics, Inc.

Effective: 2025-06-30
Filed: June 11, 2025, 7:59 PM ET

On June 10, 2025, the Board appointed Mr. Jesper Høiland as a director of the Company, effective as of June 30, 2025.

Departed

Joseph W. Vazzano

director

ALLR · Allarity Therapeutics, Inc.

Effective: 2025-06-30
Filed: June 11, 2025, 7:59 PM ET

On June 5, 2025, the Board of Directors (the “ Board ”) of Allarity Therapeutics, Inc. (the “ Company ”) received the resignation of Joseph W. Vazzano as director of the Company, effective June 30, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jesper Høiland was appointed as director at Allarity Therapeutics, Inc..

Action: appointed
Role: director

Exact text from the filing

On June 10, 2025, the Board appointed Mr. Jesper Høiland as a director of the Company, effective as of June 30, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph W. Vazzano resigned as director at Allarity Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

On June 5, 2025, the Board of Directors (the “ Board ”) of Allarity Therapeutics, Inc. (the “ Company ”) received the resignation of Joseph W. Vazzano as director of the Company, effective June 30, 2025.

View on SEC.gov

Allarity Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-020081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.